Literature DB >> 17158177

The functional nature of synaptic circuitry is altered in area CA3 of the hippocampus in a mouse model of Down's syndrome.

Jesse E Hanson1, Martina Blank, Ricardo A Valenzuela, Craig C Garner, Daniel V Madison.   

Abstract

Down's syndrome (DS) is the most common cause of mental retardation, and memory impairments are more severe in DS than in most if not all other causes of mental retardation. The Ts65Dn mouse, a genetic model of DS, exhibits phenotypes of DS, including memory impairments indicative of hippocampal dysfunction. We examined functional synaptic connectivity in area CA3 of the hippocampus of Ts65Dn mice using organotypic slice cultures as a model. We found reductions in multiple measures of synaptic function in both excitatory and inhibitory inputs to pyramidal neurons in CA3 of the Ts65Dn hippocampus. However, associational synaptic connections between pyramidal neurons were more abundant and more likely to be active rather than silent in the Ts65Dn hippocampus. Synaptic potentiation was normal in these associational connections. Decreased overall functional synaptic input onto pyramidal neurons expressed along with the specific hyperconnectivity of associational connections between pyramidal neurons will result in predictable alterations of CA3 network function, which may contribute to the memory impairments seen in DS.

Entities:  

Mesh:

Year:  2006        PMID: 17158177      PMCID: PMC2075378          DOI: 10.1113/jphysiol.2006.114868

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  40 in total

1.  Pair recordings reveal all-silent synaptic connections and the postsynaptic expression of long-term potentiation.

Authors:  J M Montgomery; P Pavlidis; D V Madison
Journal:  Neuron       Date:  2001-03       Impact factor: 17.173

2.  Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome.

Authors:  R J Siarey; E J Carlson; C J Epstein; A Balbo; S I Rapoport; Z Galdzicki
Journal:  Neuropharmacology       Date:  1999-12       Impact factor: 5.250

3.  The neuropsychology of Down syndrome: evidence for hippocampal dysfunction.

Authors:  Bruce F Pennington; Jennifer Moon; Jamie Edgin; Jennifer Stedron; Lynn Nadel
Journal:  Child Dev       Date:  2003 Jan-Feb

Review 4.  Down's syndrome.

Authors:  Nancy J Roizen; David Patterson
Journal:  Lancet       Date:  2003-04-12       Impact factor: 79.321

5.  Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function.

Authors:  L A Hyde; D F Frisone; L S Crnic
Journal:  Behav Brain Res       Date:  2001-01-08       Impact factor: 3.332

6.  Hippocampal hypocellularity in the Ts65Dn mouse originates early in development.

Authors:  Hernan A Lorenzi; Roger H Reeves
Journal:  Brain Res       Date:  2006-07-07       Impact factor: 3.252

7.  Quantitative PCR genotyping assay for the Ts65Dn mouse model of Down syndrome.

Authors:  Dong P Liu; Cecilia Schmidt; Timothy Billings; Muriel T Davisson
Journal:  Biotechniques       Date:  2003-12       Impact factor: 1.993

Review 8.  Understanding mental retardation in Down's syndrome using trisomy 16 mouse models.

Authors:  Z Galdzicki; R J Siarey
Journal:  Genes Brain Behav       Date:  2003-06       Impact factor: 3.449

9.  Differences in hippocampal neuronal population responses to modifications of an environmental context: evidence for distinct, yet complementary, functions of CA3 and CA1 ensembles.

Authors:  Almira Vazdarjanova; John F Guzowski
Journal:  J Neurosci       Date:  2004-07-21       Impact factor: 6.167

10.  Mechanisms of verbal memory impairment in four neurodevelopmental disorders.

Authors:  Sharon Nichols; Wendy Jones; Mary J Roman; Beverly Wulfeck; Dean C Delis; Judy Reilly; Ursula Bellugi
Journal:  Brain Lang       Date:  2004-02       Impact factor: 2.381

View more
  43 in total

Review 1.  Trisomy 21 and early brain development.

Authors:  Tarik F Haydar; Roger H Reeves
Journal:  Trends Neurosci       Date:  2011-12-09       Impact factor: 13.837

Review 2.  Down syndrome: from understanding the neurobiology to therapy.

Authors:  Katheleen Gardiner; Yann Herault; Ira T Lott; Stylianos E Antonarakis; Roger H Reeves; Mara Dierssen
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

3.  OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome.

Authors:  Ranjie Xu; Andrew T Brawner; Shenglan Li; Jing-Jing Liu; Hyosung Kim; Haipeng Xue; Zhiping P Pang; Woo-Yang Kim; Ronald P Hart; Ying Liu; Peng Jiang
Journal:  Cell Stem Cell       Date:  2019-05-23       Impact factor: 24.633

4.  Developmentally altered inhibition in Ts65Dn, a mouse model of Down syndrome.

Authors:  Ananya Mitra; Martina Blank; Daniel V Madison
Journal:  Brain Res       Date:  2012-01-03       Impact factor: 3.252

5.  Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome.

Authors:  Alexander M Kleschevnikov; Pavel V Belichenko; Jessica Gall; Lizzy George; Rachel Nosheny; Michael T Maloney; Ahmad Salehi; William C Mobley
Journal:  Neurobiol Dis       Date:  2011-10-17       Impact factor: 5.996

6.  Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome.

Authors:  Verónica Vidal; Susana García-Cerro; Paula Martínez; Andrea Corrales; Sara Lantigua; Rebeca Vidal; Noemí Rueda; Laurence Ozmen; Maria-Clemencia Hernández; Carmen Martínez-Cué
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

7.  The Down syndrome critical region regulates retinogeniculate refinement.

Authors:  Martina Blank; Peter G Fuerst; Beth Stevens; Navid Nouri; Lowry Kirkby; Deepti Warrier; Ben A Barres; Marla B Feller; Andrew D Huberman; Robert W Burgess; Craig C Garner
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

Review 8.  Beyond counts and shapes: studying pathology of dendritic spines in the context of the surrounding neuropil through serial section electron microscopy.

Authors:  M Kuwajima; J Spacek; K M Harris
Journal:  Neuroscience       Date:  2012-05-01       Impact factor: 3.590

9.  Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model.

Authors:  Ishita Das; Joo-Min Park; Jung H Shin; Soo Kyeong Jeon; Hernan Lorenzi; David J Linden; Paul F Worley; Roger H Reeves
Journal:  Sci Transl Med       Date:  2013-09-04       Impact factor: 17.956

10.  A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome.

Authors:  Patricia Lopes Pereira; Laetitia Magnol; Ignasi Sahún; Véronique Brault; Arnaud Duchon; Paola Prandini; Agnès Gruart; Jean-Charles Bizot; Bernadette Chadefaux-Vekemans; Samuel Deutsch; Fabrice Trovero; José María Delgado-García; Stylianos E Antonarakis; Mara Dierssen; Yann Herault
Journal:  Hum Mol Genet       Date:  2009-09-26       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.